Literature DB >> 17532534

New developments in synthetic peroxidic drugs as artemisinin mimics.

Charles W Jefford1.   

Abstract

The present review describes the current status of synthetic cyclic peroxides, trioxanes and trioxolanes that show significant promise as antimalarial drugs because of their artemisinin-like activity. The literature from 1996 onwards is critically surveyed to provide an update on how an age-old, persistent, debilitating and frequently deadly disease could be treated by new, affordable and effective medicines possessing the peroxide pharmacophore. The review is not exhaustive and does not cover recent progress on the lead structure artemisinin and its derivatives. Nevertheless, some mechanistic aspects gleaned from artemisinin that have relevance to synthetic peroxides are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532534     DOI: 10.1016/j.drudis.2007.04.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  20 in total

1.  The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials.

Authors:  Amy E Mercer; Ian M Copple; James L Maggs; Paul M O'Neill; B Kevin Park
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

2.  An asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Brønsted acid catalysis cascade.

Authors:  David M Rubush; Michelle A Morges; Barbara J Rose; Douglas H Thamm; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2012-08-07       Impact factor: 15.419

3.  Cu(II)-catalyzed aerobic hydroperoxidation of Meldrum's acid derivatives and application in intramolecular oxidation: a conceptual blueprint for O2/H2 dihydroxylation.

Authors:  Scott W Krabbe; Dung T Do; Jeffrey S Johnson
Journal:  Org Lett       Date:  2012-11-19       Impact factor: 6.005

4.  Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.

Authors:  Matthias A Fügi; Sergio Wittlin; Yuxiang Dong; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

5.  Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.

Authors:  Ranjani Maurya; Awakash Soni; Devireddy Anand; Makthala Ravi; Kanumuri S R Raju; Isha Taneja; Niraj K Naikade; S K Puri; Sanjeev Kanojiya; Prem P Yadav
Journal:  ACS Med Chem Lett       Date:  2012-12-11       Impact factor: 4.345

6.  Selection of a trioxaquine as an antimalarial drug candidate.

Authors:  Frédéric Coslédan; Laurent Fraisse; Alain Pellet; François Guillou; Benjamin Mordmüller; Peter G Kremsner; Alicia Moreno; Dominique Mazier; Jean-Pierre Maffrand; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

7.  Stability of peroxide antimalarials in the presence of human hemoglobin.

Authors:  Darren J Creek; Eileen Ryan; William N Charman; Francis C K Chiu; Richard J Prankerd; Jonathan L Vennerstrom; Susan A Charman
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

8.  The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice.

Authors:  Fatima Bousejra-El Garah; Catherine Claparols; Françoise Benoit-Vical; Bernard Meunier; Anne Robert
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

9.  Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials.

Authors:  Darren J Creek; William N Charman; Francis C K Chiu; Richard J Prankerd; Yuxiang Dong; Jonathan L Vennerstrom; Susan A Charman
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

Review 10.  Artemisinins: their growing importance in medicine.

Authors:  Sanjeev Krishna; Leyla Bustamante; Richard K Haynes; Henry M Staines
Journal:  Trends Pharmacol Sci       Date:  2008-08-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.